HPR Dr. Schaffler GmbH
Human Pharmacodynamic Research
Skip to content
  • Home
  • Company
  • Services
  • Trial Participants/Volunteers
  • Contact
  • Legal notice
  • Privacy Policy
  • German
← A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects
Important invitation by NIH to participate in “Discovery of Biomarkers to Develop Transformational Non-Addictive Therapeutics for Pain” →

A Phase I, randomized, double-blind, laser evoked potential study to evaluate the analgesic/anti-hyperalgesic effect of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects

Posted on December 20, 2017 by hprdsadmin

K. Schaffler, A. Fakhoury, W. He, P. Passier, K. Tracy, J. Paul

in print, Pain Medicine, DOI:10.1093/pm/pnx338

This entry was posted in Clinical Studies. Bookmark the permalink.
← A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects
Important invitation by NIH to participate in “Discovery of Biomarkers to Develop Transformational Non-Addictive Therapeutics for Pain” →
  • Questions?

    Contact us!
    Phone: +49-89-99322-0

HPR Dr. Schaffler GmbH
Proudly powered by WordPress.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Wir benutzen Cookies um die Darstellung unserer WebSite für Sie zu verbessern. Wenn Sie weiter unsere WebSite weiter benutzen, gehen wie davon aus, das Sie damit einverstanden sind.
OkMore / Mehr